Whittier Trust CO Enzon Pharmaceuticals, Inc. Transaction History

Whittier Trust CO

  • $7.37 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 20, 2018
BUY
$0.25 - $0.28 $168 - $189
675 New
675 $1,000

About ENZON PHARMACEUTICALS, INC.

ENZN Quotes by TradingView
  • Ticker ENZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 74,214,600
  • Market Cap $5.94M
  • Description
  • Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
More about ENZN
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email